Marine Origin Polysaccharides in Drug Delivery Systems
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pomponi, 1999, The bioprocess-technological potential of the sea, J. Biotechnol., 70, 5, 10.1016/S0168-1656(99)00053-X
Munro, 1999, The discovery and development of marine compounds with pharmaceutical potential, J. Biotechnol., 70, 15, 10.1016/S0168-1656(99)00052-8
Molinski, 2009, Drug development from marine natural products, Nat. Rev. Drug Discov., 8, 69, 10.1038/nrd2487
Schwartsmann, 2001, Marine organisms as a source of new anticancer agents, Lancet Oncol., 2, 221, 10.1016/S1470-2045(00)00292-8
Jimeno, 2004, Progress in the clinical development of new marine-derived anticancer compounds, Anticancer Drugs, 15, 321, 10.1097/00001813-200404000-00003
Newman, 2014, Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development, Mar. Drugs, 12, 255, 10.3390/md12010255
Rinehart, 2000, Antitumor compounds from tunicates, Med. Res. Rev., 20, 1, 10.1002/(SICI)1098-1128(200001)20:1<1::AID-MED1>3.0.CO;2-A
2012, Bioactive peptides and depsipeptides with anticancer potential: Sources from Marine Animals, Mar. Drugs, 10, 963, 10.3390/md10050963
Jimeno, 2002, A clinical armamentarium of marine-derived anti-cancer compounds, Anticancer Drugs, 13, S15
Valoti, 1998, Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts, Clin. Cancer Res., 4, 1977
Laurienzo, 2010, Marine polysaccharides in pharmaceutical applications: An Overview, Mar. Drugs, 8, 2435, 10.3390/md8092435
Senni, 2011, Marine polysaccharides: A source of bioactive molecules for cell therapy and tissue engineering, Mar. Drugs, 9, 1664, 10.3390/md9091664
Ngo, 2013, Sulfated polysaccharides as bioactive agents from marine algae, Int. J. Biol. Macromol., 62, 70, 10.1016/j.ijbiomac.2013.08.036
Costa, 2010, Biological activities of sulfated polysaccharides from tropical seaweeds, Biomed. Pharmacother., 64, 21, 10.1016/j.biopha.2009.03.005
Wijesekara, 2011, Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae, Carbohydr. Polym., 84, 14, 10.1016/j.carbpol.2010.10.062
Barahona, 2011, Antioxidant capacity of sulfated polysaccharides from seaweeds. A kinetic approach, Food Hydrocoll., 25, 529, 10.1016/j.foodhyd.2010.08.004
Ciancia, 2010, Overview of anticoagulant activity of sulfated polysaccharides from seaweeds in relation to their structures, focusing on those of green seaweeds, Curr. Med. Chem., 17, 2503, 10.2174/092986710791556069
Kathiresan, 2010, Anticancer drugs from marine flora: An Overview, J. Oncol., 2010, 1, 10.1155/2010/214186
Bouhlal, 2011, Antiviral activities of sulfated polysaccharides isolated from sphaerococcus coronopifolius (rhodophytha, gigartinales) and boergeseniella thuyoides (rhodophyta, ceramiales), Mar. Drugs, 9, 1187, 10.3390/md9071187
Vo, 2012, Potential targets for anti-inflammatory and anti-allergic activities of marine algae: An Overview, Inflamm. Allergy Drug Targets, 11, 90, 10.2174/187152812800392797
Cumashi, 2007, A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds, Glycobiology, 17, 541, 10.1093/glycob/cwm014
Malinconico, 2008, Marine derived polysaccharides for biomedical applications: Chemical modification approaches, Molecules, 13, 2069, 10.3390/molecules13092069
Allen, 2004, Drug delivery systems: Entering the mainstream, Science, 303, 1818, 10.1126/science.1095833
Blanchette, 2012, Nanoparticle and targeted systems for cancer therapy, Adv. Drug Deliv. Rev., 64, 206, 10.1016/j.addr.2012.09.033
Thomas, 2003, Progress and problems with the use of viral vectors for gene therapy, Nat. Rev. Genet., 4, 346, 10.1038/nrg1066
Silva, 2012, Marine algae sulfated polysaccharides for tissue engineering and drug delivery approaches, Biomatter, 2, 278, 10.4161/biom.22947
Nitta, 2013, Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering, Int. J. Mol. Sci., 14, 1629, 10.3390/ijms14011629
Lee, 2012, Alginate: Properties and biomedical applications, Prog. Polym. Sci., 37, 106, 10.1016/j.progpolymsci.2011.06.003
Haug, 1962, Quantitative determination of uronic acid compositions of alginates, Acta Chem. Scand., 16, 1908, 10.3891/acta.chem.scand.16-1908
Tonnesen, 2002, Alginate in drug delivery systems, Drug Dev. Ind. Pharm., 28, 621, 10.1081/DDC-120003853
Mano, 2008, Stimuli-responsive polymeric systems for biomedical applications, Adv. Eng. Mater., 10, 515, 10.1002/adem.200700355
George, 2006, Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan—A review, J. Control. Release, 114, 1, 10.1016/j.jconrel.2006.04.017
Chen, 2004, A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery, J. Control. Release, 96, 285, 10.1016/j.jconrel.2004.02.002
Gombotz, 2012, Protein release from alginate matrices, Adv. Drug Deliv. Rev., 64, 194, 10.1016/j.addr.2012.09.007
Beneke, 2009, Polymeric plant-derived excipients in drug delivery, Molecules, 14, 2602, 10.3390/molecules14072602
Sudhakar, 2006, Buccal bioadhesive drug delivery—A promising option for orally less efficient drugs, J. Control. Release, 114, 15, 10.1016/j.jconrel.2006.04.012
Sirkia, 1994, Biopharmaceutical evaluation of new prolonged-release press-coated ibuprofen tablets containing sodium alginate to adjust drug-release, Int. J. Pharm., 107, 179, 10.1016/0378-5173(94)90432-4
Xu, 2007, Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system, Int. J. Pharm., 336, 329, 10.1016/j.ijpharm.2006.12.019
Pillay, 1999, In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract: I. Comparison of pH-responsive drug release and associated kinetics, J. Control. Release, 59, 229, 10.1016/S0168-3659(98)00196-5
Pillay, 1999, In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract: II. Physicochemical characterization of calcium-alginate, calcium-pectinate and calcium-alginate-pectinate pellets, J. Control. Release, 59, 243, 10.1016/S0168-3659(98)00197-7
Mandal, 2010, Ca2+ ion cross-linked interpenetrating network matrix tablets of polyacrylamide-grafted-sodium alginate and sodium alginate for sustained release of diltiazem hydrochloride, Carbohydr. Polym., 82, 867, 10.1016/j.carbpol.2010.06.009
Russo, 2007, Effect of cross-linking with calcium ions on the physical properties of alginate films, Biomacromolecules, 8, 3193, 10.1021/bm700565h
Oliveira, 2013, On-chip assessment of the protein-release profile from 3D hydrogel arrays, Anal. Chem., 85, 2391, 10.1021/ac303405x
Giunchedi, 2000, Evaluation of alginate compressed matrices as prolonged drug delivery systems, AAPS PharmSciTech, 1, 31, 10.1208/pt010319
Hamidi, 2008, Hydrogel nanoparticles in drug delivery, Adv. Drug Deliv. Rev., 60, 1638, 10.1016/j.addr.2008.08.002
Draget, 1994, Alginic acid gels: The effect of alginate chemical composition and molecular weight, Carbohydr. Polym., 25, 31, 10.1016/0144-8617(94)90159-7
Mura, 2013, Stimuli-responsive nanocarriers for drug delivery, Nat. Mater., 12, 991, 10.1038/nmat3776
Duarte, 2014, Microfluidic production of perfluorocarbon-alginate core-shell microparticles for ultrasound therapeutic applications, Langmuir, 30, 12391, 10.1021/la502822v
Song, 2010, Bioinspired methodology to fabricate hydrogel spheres for multi-applications using superhydrophobic substrates, Soft Matter, 6, 5868, 10.1039/c0sm00901f
Costa, 2015, Superhydrophobic surfaces as a tool for the fabrication of hierarchical spherical polymeric carriers, Small, 11, 3648, 10.1002/smll.201500192
Costa, 2014, Biocompatible polymeric microparticles produced by a simple biomimetic approach, Langmuir, 30, 4535, 10.1021/la500286v
Thomas, 2003, Non-viral gene therapy: Polycation-mediated DNA delivery, Appl. Microbiol. Biotechnol., 62, 27, 10.1007/s00253-003-1321-8
Pack, 2005, Design and development of polymers for gene delivery, Nat. Rev. Drug Discov., 4, 581, 10.1038/nrd1775
Liu, 2008, Polysaccharides-based nanoparticles as drug delivery systems, Adv. Drug Deliv. Rev., 60, 1650, 10.1016/j.addr.2008.09.001
Panyam, 2003, Biodegradable nanoparticles for drug and gene delivery to cells and tissue, Adv. Drug Deliv. Rev., 55, 329, 10.1016/S0169-409X(02)00228-4
Quick, 2004, Delivering DNA from photocrosslinked, surface eroding polyanhydrides, J. Control. Release, 97, 333, 10.1016/j.jconrel.2004.03.001
Krebs, 2010, Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces in vivo osteogenesis, J. Biomed. Mater. Res. A, 92, 1131, 10.1002/jbm.a.32441
Becker, 2010, Layer-by-layer-assembled capsules and films for therapeutic delivery, Small, 6, 1836
Zhao, 2007, Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: Doxorubicin loading and in vitro and in vivo studies, Nanomed. NBM, 3, 63, 10.1016/j.nano.2006.11.007
Costa, 2011, Liquefied capsules coated with multilayered polyelectrolyte films for cell immobilization, Adv. Eng. Mater., 13, B218, 10.1002/adem.201080138
Mano, 2015, Designing biomaterials for tissue engineering based on the deconstruction of the native cellular environment, Mater. Lett., 141, 198, 10.1016/j.matlet.2014.11.061
Chen, 2014, Robust, flexible, and bioadhesive free-standing films for the co-delivery of antibiotics and growth factors, Langmuir, 30, 13898, 10.1021/la503684k
Caridade, 2013, Free-standing polyelectrolyte membranes made of chitosan and alginate, Biomacromolecules, 14, 1653, 10.1021/bm400314s
Jiang, 2006, Freestanding nanostructures via layer-by-layer assembly, Adv. Mater., 18, 829, 10.1002/adma.200502444
Okamura, 2009, Free-standing biodegradable poly(lactic acid) nanosheet for sealing operations in surgery, Adv. Mater., 21, 4388, 10.1002/adma.200901035
Fujie, 2009, Adhesive, flexible, and robust polysaccharide nanosheets integrated for tissue-defect repair, Adv. Funct. Mater., 19, 2560, 10.1002/adfm.200900103
Fujie, 2007, Ubiquitous transference of a free-standing polysaccharide nanosheet with the development of a nano-adhesive plaster, Adv. Mater., 19, 3549, 10.1002/adma.200700661
Silva, 2014, Tailored freestanding multilayered membranes based on chitosan and alginate, Biomacromolecules, 15, 3817, 10.1021/bm501156v
Costa, 2014, Polyelectrolyte multilayered assemblies in biomedical technologies, Chem. Soc. Rev., 43, 3453, 10.1039/c3cs60393h
Zhang, 2011, Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin, Eur. J. Pharm. Biopharm., 77, 11, 10.1016/j.ejpb.2010.09.016
Lima, 2012, Production methodologies of polymeric and hydrogel particles for drug delivery applications, Expert Opin. Drug Deliv., 9, 231, 10.1517/17425247.2012.652614
Soppimath, 2001, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release, 70, 1, 10.1016/S0168-3659(00)00339-4
Ribeiro, 1999, Microencapsulation of lipophilic drugs in chitosan-coated alginate microspheres, Int. J. Pharm., 187, 115, 10.1016/S0378-5173(99)00173-8
Lin, 2005, Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs, Biomaterials, 26, 2105, 10.1016/j.biomaterials.2004.06.011
Chandy, 1998, Chitosan polyethylene glycol alginate microcapsules for oral delivery of hirudin, J. Appl. Polym. Sci., 70, 2143, 10.1002/(SICI)1097-4628(19981212)70:11<2143::AID-APP7>3.0.CO;2-L
Schmaljohann, 2006, Thermo- and pH-responsive polymers in drug delivery, Adv. Drug Deliv. Rev., 58, 1655, 10.1016/j.addr.2006.09.020
Prabaharan, 2006, Stimuli-responsive hydrogels based on polysaccharides incorporated with thermo-responsive polymers as novel biomaterials, Macromol. Biosci., 6, 991, 10.1002/mabi.200600164
Shi, 2008, Chitosan coated alginate beads containing poly(N-isopropylacrylamide) for dual-stimuli-responsive drug release, J. Biomed. Mater. Res. B Appl. Biomater., 84, 595, 10.1002/jbm.b.30907
Sarmento, 2007, Alginate/chitosan nanoparticles are effective for oral insulin delivery, Pharm. Res., 24, 2198, 10.1007/s11095-007-9367-4
Correia, 2013, Multilayered hierarchical capsules providing cell adhesion sites, Biomacromolecules, 14, 743, 10.1021/bm301833z
Correia, 2013, Liquified chitosan-alginate multilayer capsules incorporating poly(l-lactic acid) microparticles as cell carriers, Soft Matter, 9, 2125, 10.1039/C2SM26784E
Rinaudo, 2008, Main properties and current applications of some polysaccharides as biomaterials, Polym. Int., 57, 397, 10.1002/pi.2378
Li, 2014, Carrageenan and its applications in drug delivery, Carbohydr. Polym., 103, 1, 10.1016/j.carbpol.2013.12.008
Picker, 1999, Matrix tablets of carrageenans. I. A compaction study, Drug Dev. Ind. Pharm., 25, 329, 10.1081/DDC-100102178
Silva, 2010, Anticoagulant activity, paw edema and pleurisy induced carrageenan: Action of major types of commercial carrageenans, Carbohydr. Polym., 79, 26, 10.1016/j.carbpol.2009.07.010
Zhou, 2004, In vivo antitumor and immunomodulation activities of different molecular weight lambda-carrageenans from Chondrus ocellatus, Pharmacol. Res., 50, 47, 10.1016/j.phrs.2003.12.002
Panlasigui, 2003, Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers, Asia Pac. J. Clin. Nutr., 12, 209
Marques, 2007, Antioxidant activities of sulfated polysaccharides from brown and red seaweeds, J. Appl. Phycol., 19, 153, 10.1007/s10811-006-9121-z
Carlucci, 1999, Antiherpetic activity and mode of action of natural carrageenans of diverse structural types, Antiviral Res., 43, 93, 10.1016/S0166-3542(99)00038-8
Campo, 2009, Carrageenans: Biological properties, chemical modifications and structural analysis—A review, Carbohydr. Polym., 77, 167, 10.1016/j.carbpol.2009.01.020
Schaeffer, 2000, Anti-HIV activity of extracts and compounds from algae and cyanobacteria, Ecotoxicol. Environ. Saf., 45, 208, 10.1006/eesa.1999.1862
Carlucci, 2004, Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice, Antiviral Res., 64, 137, 10.1016/j.antiviral.2004.07.001
Prajapati, 2014, Carrageenan: A natural seaweed polysaccharide and its applications, Carbohydr. Polym., 105, 97, 10.1016/j.carbpol.2014.01.067
Bornhoft, 2005, Preliminary assessment of carrageenan as excipient for extrusion/spheronisation, Eur. J. Pharm. Biopharm., 59, 127, 10.1016/j.ejpb.2004.05.007
Bonferoni, 1998, On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix, J. Control. Release, 51, 231, 10.1016/S0168-3659(97)00175-2
Mohamadnia, 2007, pH-sensitive IPN hydrogel beads of carrageenan-alginate for controlled drug delivery, J. Bioact. Compat. Polym., 22, 342, 10.1177/0883911507078519
Ganta, 2008, A review of stimuli-responsive nanocarriers for drug and gene delivery, J. Control. Release, 126, 187, 10.1016/j.jconrel.2007.12.017
Meyer, 2001, Drug targeting using thermally responsive polymers and local hyperthermia, J. Control. Release, 74, 213, 10.1016/S0168-3659(01)00319-4
Popa, 2013, Cryopreservation of cell laden natural origin hydrogels for cartilage regeneration strategies, Soft Matter, 9, 875, 10.1039/C2SM26846A
Popa, 2015, Chondrogenic potential of injectable kappa-carrageenan hydrogel with encapsulated adipose stem cells for cartilage tissue-engineering applications, J. Tissue Eng. Regen. Med., 9, 550, 10.1002/term.1683
Rocha, 2011, Encapsulation of adipose-derived stem cells and transforming growth factor-β1 in carrageenan-based hydrogels for cartilage tissue engineering, J. Bioact. Compat. Polym., 26, 493, 10.1177/0883911511420700
Luna, 2010, Development of a novel cell encapsulation system based on natural origin polymers for tissue engineering applications, J. Bioact. Compat. Polym., 25, 341, 10.1177/0883911510372173
Gasperini, 2014, Natural polymers for the microencapsulation of cells, J. R. Soc. Interface, 11, 1, 10.1098/rsif.2014.0817
Popa, 2011, Cell delivery systems using alginate—Carrageenan hydrogel beads and fibers for regenerative medicine applications, Biomacromolecules, 12, 3952, 10.1021/bm200965x
Grenha, 2010, Development of new chitosan/carrageenan nanoparticles for drug delivery applications, J. Biomed. Mater. Res. A, 92, 1265, 10.1002/jbm.a.32466
Oliveira, 2013, Nanocoatings containing sulfated polysaccharides prepared by layer-by-layer assembly as models to study cell-material interactions, J. Mater. Chem. B, 1, 4406, 10.1039/c3tb20624f
Yeo, 2001, Microencapsulation methods for delivery of protein drugs, Biotechnol. Bioprocess. Eng., 6, 213, 10.1007/BF02931982
Rodrigues, 2012, Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios, Carbohydr. Polym., 89, 282, 10.1016/j.carbpol.2012.03.010
Ermakova, 2011, Fucoidans from brown seaweeds sargassum hornery, eclonia cava, costaria costata: Structural characteristics and anticancer activity, Appl. Biochem. Biotechnol., 164, 841, 10.1007/s12010-011-9178-2
Anastyuk, 2012, Anticancer activity in vitro of a fucoidan from the brown alga fucus evanescens and its low-molecular fragments, structurally characterized by tandem mass-spectrometry, Carbohydr. Polym., 87, 186, 10.1016/j.carbpol.2011.07.036
Kim, 2008, Prospective of the cosmeceuticals derived from marine organisms, Biotechnol. Bioprocess. Eng., 13, 511, 10.1007/s12257-008-0113-5
Zilberman, 2011, Fucoidan: A versatile biopolymer for biomedical applications, Active Implants and Scaffolds for Tissue Regeneration, Volume 8, 377, 10.1007/8415_2011_67
Sezer, 2006, Fucosphere—New microsphere carriers for peptide and protein delivery: Preparation and in vitro characterization, J. Microencapsul., 23, 513, 10.1080/02652040600687563
Sezer, 2008, The use of fucosphere in the treatment of dermal burns in rabbits, Eur. J. Pharm. Biopharm., 69, 189, 10.1016/j.ejpb.2007.09.004
Huang, 2014, Preparation and characterization of antioxidant nanoparticles composed of chitosan and fucoidan for antibiotics delivery, Mar. Drugs, 12, 4379, 10.3390/md12084379
Nakamura, 2008, Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization, J. Biomed. Mater. Res. A, 85, 619, 10.1002/jbm.a.31563
Sato, 2012, Layer-by-layer thin films and microcapsules for biosensors and controlled release, Anal. Sci., 28, 929, 10.2116/analsci.28.929
Pinheiro, 2015, Chitosan/fucoidan multilayer nanocapsules as a vehicle for controlled release of bioactive compounds, Carbohydr. Polym., 115, 1, 10.1016/j.carbpol.2014.07.016
Lahaye, 2007, Structure and functional properties of ulvan, a polysaccharide from green seaweeds, Biomacromolecules, 8, 1765, 10.1021/bm061185q
Alves, 2013, In vitro cytotoxicity assessment of ulvan, a polysaccharide extracted from green algae, Phytother. Res., 27, 1143, 10.1002/ptr.4843
Ahmed, 2014, Anti-proliferative and apoptotic efficacies of ulvan polysaccharides against different types of carcinoma cells in vitro and in vivo, J. Cancer Sci. Ther., 6, 202, 10.4172/1948-5956.1000272
Alves, 2013, A practical perspective on ulvan extracted from green algae, J. Appl. Phycol., 25, 407, 10.1007/s10811-012-9875-4
Dash, 2014, Biofunctionalization of ulvan scaffolds for bone tissue engineering, ACS Appl. Mater. Interfaces, 6, 3211, 10.1021/am404912c
Alves, 2012, Processing ulvan into 2D structures: Cross-linked ulvan membranes as new biomaterials for drug delivery applications, Int. J. Pharm., 426, 76, 10.1016/j.ijpharm.2012.01.021
Alves, 2012, PDLLA enriched with ulvan particles as a novel 3D porous scaffold targeted for bone engineering, J. Supercrit. Fluids, 65, 32, 10.1016/j.supflu.2012.02.023
Morelli, 2010, Ulvan as a new type of biomaterial from renewable resources: Functionalization and hydrogel preparation, Macromol. Chem. Phys., 211, 821, 10.1002/macp.200900562
Toskas, 2012, Ulvan and ulvan/chitosan polyelectrolyte nanofibrous membranes as a potential substrate material for the cultivation of osteoblasts, Carbohydr. Polym., 89, 997, 10.1016/j.carbpol.2012.04.045
Barros, 2013, Carboxymethylation of ulvan and chitosan and their use as polymeric components of bone cements, Acta Biomater., 9, 9086, 10.1016/j.actbio.2013.06.036
Bansal, 2011, Applications of chitosan and chitosan derivatives in drug delivery, Adv. Biol. Res., 5, 28
Rinaudo, 2006, Chitin and chitosan: Properties and applications, Prog. Polym. Sci., 31, 603, 10.1016/j.progpolymsci.2006.06.001
Alves, 2008, Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications, Int. J. Biol. Macromol., 43, 401, 10.1016/j.ijbiomac.2008.09.007
Varum, 1997, In vitro degradation rates of partially N-acetylated chitosans in human serum, Carbohydr. Res., 299, 99, 10.1016/S0008-6215(96)00332-1
Agnihotri, 2004, Recent advances on chitosan-based micro- and nanoparticles in drug delivery, J. Control. Release, 100, 5, 10.1016/j.jconrel.2004.08.010
Sinha, 2004, Chitosan microspheres as a potential carrier for drugs, Int. J. Pharm., 274, 1, 10.1016/j.ijpharm.2003.12.026
Prabaharan, 2005, Chitosan-based particles as controlled drug delivery systems, Drug Deliv., 12, 41, 10.1080/10717540590889781
Couto, 2009, Development of bioactive and biodegradable chitosan-based injectable systems containing bioactive glass nanoparticles, Acta Biomater., 5, 115, 10.1016/j.actbio.2008.08.006
Rabea, 2003, Chitosan as antimicrobial agent: Applications and mode of action, Biomacromolecules, 4, 1457, 10.1021/bm034130m
Kim, 2008, Chitosan and its derivatives for tissue engineering applications, Biotechnol. Adv., 26, 1, 10.1016/j.biotechadv.2007.07.009
Qin, 2002, Enzymic preparation of water-soluble chitosan and their antitumor activity, Int. J. Biol. Macromol., 31, 111, 10.1016/S0141-8130(02)00064-8
Chung, 2012, Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE-antigen complex-stimulated RBL-2H3 cells and asthma model mice, Int. Immunopharmacol., 12, 453, 10.1016/j.intimp.2011.12.027
Ilium, 1998, Chitosan and its use as a pharmaceutical excipient, Pharm. Res., 15, 1326, 10.1023/A:1011929016601
Singla, 2001, Chitosan: Some pharmaceutical and biological aspects—An update, J. Pharm. Pharmacol., 53, 1047, 10.1211/0022357011776441
Bhise, 2008, Effect of drying methods on swelling, erosion and drug release from chitosan-naproxen sodium complexes, AAPS PharmSciTech, 9, 1, 10.1208/s12249-007-9001-0
Felt, 1998, Chitosan: A unique polysaccharide for drug delivery, Drug Dev. Ind. Pharm., 24, 979, 10.3109/03639049809089942
Prabaharan, 2007, Carboxymethyl chitosan-graft-phosphatidylethanolamine: Amphiphilic matrices for controlled drug delivery, React. Funct. Polym., 67, 43, 10.1016/j.reactfunctpolym.2006.09.001
Prabaharan, 2005, Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: Synthesis and slow release of its inclusion complex with a model hydrophobic drug, Macromol. Biosci., 5, 965, 10.1002/mabi.200500087
Jayakumar, 2007, Synthesis and characterization of pH-sensitive thiol-containing chitosan beads for controlled drug delivery applications, Drug Deliv., 14, 9, 10.1080/10717540600739872
Prabaharan, 2007, A novel pH and thermo-sensitive N,O-carboxymethyl chitosan-graft-poly(N-isopropylacrylamide) hydrogel for controlled drug delivery, E-Polymers, 7, 503, 10.1515/epoly.2007.7.1.503
Lacroix, 2003, N-acylated chitosan: Hydrophobic matrices for controlled drug release, J. Control. Release, 93, 1, 10.1016/S0168-3659(03)00327-4
Martin, 2003, Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels, Eur. J. Pharm. Biopharm., 55, 35, 10.1016/S0939-6411(02)00118-2
Jiang, 2006, Novel polymer micelles prepared from chitosan grafted hydrophobic palmitoyl groups for drug delivery, Mol. Pharm., 3, 152, 10.1021/mp050010c
Wijekoon, 2013, Fluorinated methacrylamide chitosan hydrogel systems as adaptable oxygen carriers for wound healing, Acta Biomater., 9, 5653, 10.1016/j.actbio.2012.10.034
Prashanth, 2007, Chitin/chitosan: Modifications and their unlimited application potential—An overview, Trends Food Sci. Technol., 18, 117, 10.1016/j.tifs.2006.10.022
Thanou, 2001, Oral drug absorption enhancement by chitosan and its derivatives, Adv. Drug Deliv. Rev., 52, 117, 10.1016/S0169-409X(01)00231-9
Andrade, 2011, Chitosan-grafted copolymers and chitosan-ligand conjugates as matrices for pulmonary drug delivery, Int. J. Carbohydr. Chem., 2011, 1, 10.1155/2011/865704
Zhang, 2002, Properties and biocompatibility of chitosan films modified by blending with PEG, Biomaterials, 23, 2641, 10.1016/S0142-9612(01)00403-3
Casettari, 2012, PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications, Prog. Polym. Sci., 37, 659, 10.1016/j.progpolymsci.2011.10.001
Prego, 2006, Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery, Pharm. Res., 23, 549, 10.1007/s11095-006-9570-8
Mao, 2005, Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells, Pharm. Res., 22, 2058, 10.1007/s11095-005-8175-y
Mao, 2005, Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers, Biomaterials, 26, 6343, 10.1016/j.biomaterials.2005.03.036
Zhang, 2008, Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles, Eur. J. Pharm. Biopharm., 68, 526, 10.1016/j.ejpb.2007.08.009
Jintapattanakit, 2007, Peroral delivery of insulin using chitosan derivatives: A comparative study of polyelectrolyte nanocomplexes and nanoparticles, Int. J. Pharm., 342, 240, 10.1016/j.ijpharm.2007.05.015
Bhattarai, 2005, PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release, J. Control. Release, 103, 609, 10.1016/j.jconrel.2004.12.019
Wu, 2006, A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate, Int. J. Pharm., 315, 1, 10.1016/j.ijpharm.2006.01.045
Wu, 2007, A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system, Biomaterials, 28, 2220, 10.1016/j.biomaterials.2006.12.024
Nazar, 2011, Thermosensitive hydrogels for nasal drug delivery: The formulation and characterisation of systems based on N-trimethyl chitosan chloride, Eur. J. Pharm. Biopharm., 77, 225, 10.1016/j.ejpb.2010.11.022
Tahrir, 2015, Injectable thermosensitive chitosan/glycerophosphate-based hydrogels for tissue engineering and drug delivery applications: A review, Recent Pat. Drug Deliv. Formul., 9, 107, 10.2174/1872211308666141028145651
Roy, 1999, Oral gene delivery with chitosan—DNA nanoparticles generates immunologic protection in a murine model of peanut allergy, Nat. Med., 5, 387, 10.1038/7385
Borchard, 2001, Chitosans for gene delivery, Adv. Drug Deliv. Rev., 52, 145, 10.1016/S0169-409X(01)00198-3
Sato, 2001, In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency, Biomaterials, 22, 2075, 10.1016/S0142-9612(00)00385-9
Leong, 1998, DNA-polycation nanospheres as non-viral gene delivery vehicles, J. Control. Release, 53, 183, 10.1016/S0168-3659(97)00252-6
Saranya, 2011, Chitosan and its derivatives for gene delivery, Int. J. Biol. Macromol., 48, 234, 10.1016/j.ijbiomac.2010.11.013
Demeester, 2000, Cationic polymer based gene delivery systems, Pharm. Res., 17, 113, 10.1023/A:1007548826495
Cho, 2003, Polycation gene delivery systems: Escape from endosomes to cytosol, J. Pharm. Pharmacol., 55, 721, 10.1211/002235703765951311
Kean, 2005, Trimethylated chitosans as non-viral gene delivery vectors: Cytotoxicity and transfection efficiency, J. Control. Release, 103, 643, 10.1016/j.jconrel.2005.01.001
Kievit, 2009, PEI–PEG–chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: Synthesis, complexation, and transfection, Adv. Funct. Mater., 19, 2244, 10.1002/adfm.200801844
Costa, 2013, Nanostructured and thermoresponsive recombinant biopolymer-based microcapsules for the delivery of active molecules, Nanomed. NBM, 9, 895, 10.1016/j.nano.2013.01.013
Afratis, 2012, Glycosaminoglycans: Key players in cancer cell biology and treatment, FEBS J., 279, 1177, 10.1111/j.1742-4658.2012.08529.x
Burdick, 2011, Hyaluronic acid hydrogels for biomedical applications, Adv. Mater., 23, H41, 10.1002/adma.201003963
Kogan, 2007, Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications, Biotechnol. Lett., 29, 17, 10.1007/s10529-006-9219-z
Lee, 2008, Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes, Biomaterials, 29, 4709, 10.1016/j.biomaterials.2008.08.038
Chen, 1999, Functions of hyaluronan in wound repair, Wound Repair Regen., 7, 79, 10.1046/j.1524-475X.1999.00079.x
Kim, 2006, A novel approach to the production of hyaluronic acid by streptococcus zooepidemicus, J. Microbiol. Biotechnol., 16, 1849
Vazquez, 2009, High production of hyaluronic and lactic acids by Streptococcus zooepidemicus in fed-batch culture using commercial and marine peptones from fishing by-products, Biochem. Eng. J., 44, 125, 10.1016/j.bej.2008.11.007
Rangaswamy, 2008, An efficient process for production and purification of hyaluronic acid from Streptococcus equi subsp. Zooepidemicus, Biotechnol. Lett., 30, 493, 10.1007/s10529-007-9562-8
Murado, 2012, Optimization of extraction and purification process of hyaluronic acid from fish eyeball, Food Bioprod. Process., 90, 491, 10.1016/j.fbp.2011.11.002
Zhong, 1994, Biodegradation of hyaluronic acid derivatives by hyaluronidase, Biomaterials, 15, 359, 10.1016/0142-9612(94)90248-8
Lokeshwar, 2001, Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer, J. Biol. Chem., 276, 11922, 10.1074/jbc.M008432200
Rousseau, 2007, Biological markers in osteoarthritis, Nat. Clin. Pract. Rheumatol., 3, 346, 10.1038/ncprheum0508
Santos, 2010, New thermo-responsive hydrogels based on poly (N-isopropylacrylamide)/hyaluronic acid semi-interpenetrated polymer networks: Swelling properties and drug release studies, J. Bioact. Compat. Polym., 25, 169, 10.1177/0883911509357863
Kurisawa, M., Chung, J.E., Yang, Y.Y., Gao, S.J., and Uyama, H. (2005). Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chem. Commun., 4312–4314.
Lee, 2009, An injectable hyaluronic acid-tyramine hydrogel system for protein delivery, J. Control. Release, 134, 186, 10.1016/j.jconrel.2008.11.028
Xu, 2015, Hyaluronidase-incorporated hyaluronic acid-tyramine hydrogels for the sustained release of trastuzumab, J. Control. Release, 216, 47, 10.1016/j.jconrel.2015.08.015
Brea, 2009, Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma, Int. J. Pharm., 381, 122, 10.1016/j.ijpharm.2009.04.009
Lim, 2000, Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan, J. Control. Release, 66, 281, 10.1016/S0168-3659(99)00285-0
Seijo, 2008, Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy, Invest. Ophthalmol. Vis. Sci., 49, 2016, 10.1167/iovs.07-1077
Parraga, 2011, Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells, Mol. Vis., 17, 279
Grech, 2008, Chitosan beads as templates for layer-by-layer assembly and their application in the sustained release of bioactive agents, J. Bioact. Compat. Polym., 23, 367, 10.1177/0883911508093389
Simoes, 2004, On the formulation of pH-sensitive liposomes with long circulation times, Adv. Drug Deliv. Rev., 56, 947, 10.1016/j.addr.2003.10.038
Jiang, 2012, Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery, Biomaterials, 33, 9246, 10.1016/j.biomaterials.2012.09.027
Kramer, 2011, Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis, Cancer, 117, 1197, 10.1002/cncr.25565
Luo, 2000, Cross-linked hyaluronic acid hydrogel films: New biomaterials for drug delivery, J. Control. Release, 69, 169, 10.1016/S0168-3659(00)00300-X
Xuefei, 2011, Biological applications of hyaluronic acid functionalized nanomaterials, Petite and Sweet: Glyco-Nanotechnology as a Bridge to New Medicines, Volume 1091, 181
Lokeshwar, 2000, Urinary hyaluronic acid and hyaluronidase: Markers for bladder cancer detection and evaluation of grade, J. Urol., 163, 348, 10.1016/S0022-5347(05)68050-0
Leroy, 2004, Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and hyaluronic acid, Am. J. Gastroenterol., 99, 271, 10.1111/j.1572-0241.2004.04055.x
Teien, 1976, The anticoagulant effect of heparan sulfate and dermatan sulfate, Thromb. Res., 8, 859, 10.1016/0049-3848(76)90014-1
Lindahl, 1994, More to heparin than anticoagulation, Thromb. Res., 75, 1, 10.1016/0049-3848(94)90136-8
Clegg, 2006, Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis, N. Engl. J. Med., 354, 795, 10.1056/NEJMoa052771
Wang, 2007, Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration, Nat. Mater., 6, 385, 10.1038/nmat1890
Santo, 2012, Chitosan-chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine, J. Tissue Eng. Regener. Med., 6, S47, 10.1002/term.1519
Zhao, 2015, Chondroitin sulfate-based nanocarriers for drug/gene delivery, Carbohydr. Polym., 133, 391, 10.1016/j.carbpol.2015.07.063
Strehin, 2010, A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel, Biomaterials, 31, 2788, 10.1016/j.biomaterials.2009.12.033
Guo, 2014, Facile preparation of hydroxyapatite-chondroitin sulfate hybrid mesoporous microrods for controlled and sustained release of antitumor drugs, Mater. Lett., 125, 111, 10.1016/j.matlet.2014.03.084
Vitale, 2013, Dermatan sulfate: An alternative to unfractionated heparin for anticoagulation in hemodialysis patients, J. Nephrol., 26, 158, 10.5301/jn.5000105
Mourao, 1999, Searching for alternatives to heparin: Sulfated fucans from marine invertebrates, Trends Cardiovasc. Med., 9, 225, 10.1016/S1050-1738(00)00032-3
Davenport, 2012, Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments, Pediatr. Nephrol., 27, 1869, 10.1007/s00467-012-2129-5
Trowbridge, 2002, Dermatan sulfate: New functions from an old glycosaminoglycan, Glycobiology, 12, 117R, 10.1093/glycob/cwf066
Kreuger, 2006, Interactions between heparan sulfate and proteins: The concept of specificity, J. Cell. Biol., 174, 323, 10.1083/jcb.200604035
Kovalszky, 1998, Inhibition of DNA topoisomerase I activity by heparin sulfate and modulation by basic fibroblast growth factor, Mol. Cell. Biochem., 183, 11, 10.1023/A:1006898920637
Sasisekharan, 2002, Roles of heparan-sulphate glycosaminoglycans in cancer, Nat. Rev. Cancer, 2, 521, 10.1038/nrc842
Stewart, 2014, Heparan sulfate in the nucleus and its control of cellular functions, Matrix Biol., 35, 56, 10.1016/j.matbio.2013.10.009
Vlodavsky, 2007, Heparanase: Structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate, Curr. Pharm. Des., 13, 2057, 10.2174/138161207781039742
Lindahl, 2013, Pathophysiology of heparan sulphate: Many diseases, few drugs, J. Intern. Med., 273, 555, 10.1111/joim.12061
Knelson, 2014, Heparan sulfate signaling in cancer, Trends Biochem. Sci., 39, 277, 10.1016/j.tibs.2014.03.001
Kuberan, B., Hiroshi, N., and Desai, U.R. (2015). Glycosaminoglycans, Springer.
Geisert, 1996, Up-regulation of a keratan sulfate proteoglycan following cortical injury in neonatal rats, Int. J. Dev. Neurosci., 14, 257, 10.1016/0736-5748(96)00012-3
Ueno, 2015, Keratan sulfate exacerbates experimental autoimmune encephalomyelitis, J. Neurosci. Res., 93, 1874, 10.1002/jnr.23640
Usov, 1998, Structural analysis of red seaweed galactans of agar and carrageenan groups, Food Hydrocoll., 12, 301, 10.1016/S0268-005X(98)00018-6
Hoare, 2008, Hydrogels in drug delivery: Progress and challenges, Polymer, 49, 1993, 10.1016/j.polymer.2008.01.027